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Abstract
Background: The pork tapeworm, Taenia solium, and associated human infections, taeniasis, cysticercosis and
neurocysticercosis, are serious public health problems, especially in developing countries. The World Health
Organization (WHO) has set goals for having a validated strategy for control and elimination of T. solium taeniasis/
cysticercosis by 2015 and interventions scaled-up in selected countries by 2020. Timely achievement of these
internationally-endorsed targets requires that the relative benefits and effectiveness of potential interventions be
explored rigorously within a quantitative framework.
Methods: A deterministic, compartmental transmission model (EPICYST) was developed to capture the dynamics of
the taeniasis/cysticercosis disease system in the human and pig hosts. Cysticercosis prevalence in humans, an outcome
of high epidemiological and clinical importance, was explicitly modelled. A next generation matrix approach was used
to derive an expression for the basic reproduction number, R0. A full sensitivity analysis was performed using a
methodology based on Latin-hypercube sampling partial rank correlation coefficient index.
Results: EPICYST outputs indicate that chemotherapeutic intervention targeted at humans or pigs would be highly
effective at reducing taeniasis and cysticercosis prevalence when applied singly, with annual chemotherapy of humans
and pigs resulting, respectively, in 94 and 74% of human cysticercosis cases averted. Improved sanitation, meat
inspection and animal husbandry are less effective but are still able to reduce prevalence singly or in combination. The
value of R0 for taeniasis was estimated at 1.4 (95% Credible Interval: 0.5–3.6).
Conclusions: Human- and pig-targeted drug-focussed interventions appear to be the most efficacious approach from
the options currently available. The model presented is a forward step towards developing an informed control and
elimination strategy for cysticercosis. Together with its validation against field data, EPICYST will be a valuable tool to
help reach the WHO goals and to conduct economic evaluations of interventions in varying epidemiological settings.
Keywords: Cysticercosis, Neurocysticercosis, Taeniasis, Taenia solium, Tapeworm, Intervention, Mathematical modelling,
EPICYST, Latin-hypercube sampling, Partial rank correlation coefficient index, Basic reproduction number
* Correspondence: m.basanez@imperial.ac.uk
3Department of Infectious Disease Epidemiology, School of Public Health,
Faculty of Medicine, Imperial College London, St Mary’s Campus, London W2
1PG, UK
5London Centre for Neglected Tropical Disease Research, Department of
Infectious Disease Epidemiology, School of Public Health, Faculty of
Medicine, Imperial College London, St Mary’s Campus, London W2 1PG, UK
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Winskill et al. Parasites & Vectors  (2017) 10:73 
DOI 10.1186/s13071-017-1988-9
Background
The persistence of infections by the pork tapeworm,
Taenia solium, and the associated conditions of cysticer-
cosis and neurocysticercosis remain a major public health
concern, especially in impoverished communities that are
highly dependent on pig farming [1]. The roadmap set out
by the World Health Organization (WHO) in 2012 to
overcome the impact of 17 prioritised neglected tropical
diseases (NTDs) called for a validated strategy, by 2015,
for the control and elimination of T. solium taeniasis and
cysticercosis. This roadmap also called for the implemen-
tation of scaled-up interventions with the aim of control
and elimination in selected countries by 2020 [2]. Neuro-
cysticercosis remains one of the foremost causes of epi-
lepsy in developing countries [3]; a recent systematic
review estimated that 29.0% [95% confidence intervals
(95% CI): 22.9–35.5%] of people with epilepsy were also
afflicted with neurocysticercosis [4].
The multi-host life-cycle of T. solium and complica-
tions associated with humans becoming accidental dead-
end hosts - resulting in the development of cysticercosis
and, in some cases, the potentially fatal neurocysticerco-
sis - lead to complex transmission dynamics. The vari-
ous stages of the life-cycle, through the pig and human
hosts, as well as the interface between parasite eggs and
the environment provide a wide range of possible targets
for control interventions. Whilst a variety of potential
interventions have shown promise in their ability to con-
trol taeniasis and cysticercosis, there remains a number
of challenges that must be overcome to facilitate the
control and elimination of taeniasis and cysticercosis as
public health problems and help the WHO to achieve its
2020 goals [5]. These include further development of
new drugs and accessible diagnostics in humans,
conducting randomised clinical field trials to assess pig-
focussed strategies such as drug treatment and vacci-
nation, implementing a progression of behaviour-change
interventions, and building transmission models to as-
sess intervention strategies [6].
Current intervention strategies targeted at the pig-
stage of the life-cycle include chemotherapeutic
treatment and vaccination. The development and field-
testing of vaccines that protect pigs from porcine cysti-
cercosis are promising. A number of potential vaccines
has been developed, with the S3Pvac [7, 8] and TSOL18
[9, 10] vaccines being the most encouraging, field evalu-
ated, candidates. A small field trial of the TSOL18 vac-
cine in Cameroon demonstrated that the vaccine could
be highly effective in the field [11]. A second option to
target the infection in the intermediate host is anthel-
mintic chemotherapy of pigs. The most likely candidate
for this intervention strategy is oxfendazole, which has
performed well at controlling the parasite in pigs
[12–14] and has also been shown to be effective in
the field [15]. However, treatment using oxfendazole
can lead to necrotic lesions causing issues when con-
suming or selling treated pork that harboured a heavy
cyst burden [16].
Anthelmintic treatment of humans is an attractive op-
tion. Indeed, human treatment, with praziquantel or
niclosamide, has been proposed and trialled with some
success [17–21]. However, to date, there has not been
wide scale roll out of easily accessible, affordable and re-
liable diagnostic tests to discriminate between taeniasis
and cysticercosis infection. Diagnostics are important
because treatment with praziquantel can be a potential
cause of severe adverse effects (SAEs) as the drug is
cysticidal and can cause inflammation around dying
cysts in those with cysticercosis. Praziquantel therapy at
high doses in people harbouring a large number of oc-
cult cysticerci may lead to severe neurological outcomes
[22]. This raises some concerns for schistosomiasis con-
trol programmes that deliver praziquantel at large scale
in areas where the co-endemicity with T. solium is un-
known. The impact of praziquantel on a community co-
endemic for schistosomiasis and T. solium is the subject
of an ongoing study in Malawi. The concerns about
praziquantel-induced SAEs, combined with high logis-
tical costs have led the focus of human preventative
chemotherapy (PCT) away from mass drug administra-
tion (MDA) [16], a strategy otherwise endorsed by the
WHO for the control of human helminthiases.
A number of behavioural, educational and infrastruc-
tural interventions target a variety of points throughout
the life-cycle of the parasite. Meat inspection, to screen
out infected pork, is one option, although a lack of sen-
sitivity in visual examination, poorly implemented prac-
tice and avoidance of such schemes by farmers and pig
traders have been problematic in past efforts [23].
Changes to pig-husbandry practices such as indoor-
rearing or corralling, aimed at limiting the contact
between pigs and the infectious agent (eggs) in the en-
vironment, have been proposed but have proven hard to
implement in resource-limited settings [24]. A field trial
of a health-education intervention in Tanzania has demon-
strated how difficult it is to instigate large impacts on
taeniasis or cysticercosis infection levels through be-
havioural change [25]. Public education interventions have
been shown to be efficacious although their sustainabil-
ity has not been ascertained [25]. Improved sanitation
infrastructure may be effective but is reliant, in part, on
economic factors out of the control of a specific inter-
vention effort.
Mathematical modelling of the transmission dynamics
of T. solium has the potential to be a powerful tool with
which the problem of control and elimination of taenia-
sis and cysticercosis can be interrogated. As for many
NTDs, and specifically helminth infections, there is
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much scope for the further development, improved param-
eterisation, implementation and validation of trans-
mission models that allow intervention impacts to be
accurately assessed [26, 27]. As well as providing a tool
for evaluating interventions, mathematical models may
also be used to identify key knowledge gaps and uncer-
tainties which must be addressed to further our under-
standing of the system.
Two previously published models of T. solium transmis-
sion dynamics have approached the problem from both
the deterministic [28] and stochastic [29] standpoints. The
Reed-Frost framework presented by Kyvsgaard et al. [28]
is the single published reference point for deterministic
modelling of this system. This model was used to explore
T. solium transmission dynamics and to assess a range of
interventions. We have built upon the foundation laid
down by this model and present EPICYST, a (determinis-
tic) full transmission model capturing the life-cycle of T.
solium as well as the dynamics of taeniasis and cysticerco-
sis in the human population, of cysticercosis in the por-
cine population, and of T. solium eggs in the environment.
The EPICYST model is also used to derive an expres-
sion for the basic reproduction number, R0, of the in-
fection. Derivations of R0 for helminths have focussed
on dioecious (separate sexes) species using infection
intensity frameworks [30], but T. solium is hermaph-
rodite and a prevalence framework here is appropriate.
We illustrate our results by assessing the projected
impact of a suite of interventions and combinations
of interventions against cysticercosis. Uncertainties
and knowledge gaps are rigorously explored with a
full sensitivity analysis.
Methods
The EPICYST model
Our deterministic, compartmental model tracks the host
populations (humans, pigs) infected with the parasite as
well as the parasite transmission stages (gravid proglot-
tides/eggs) in the environment. Specific compartments
are included to model the prevalence of cysticercosis in
humans. A diagram of the model, associated parameters
and parameter values are shown in Fig. 1, Tables 1 and
2, respectively.
Assumptions
EPICYST has a number of simplifying assumptions. Both
human and pig population sizes remain constant through-
out. We assume that humans do not develop immunity to
reinfection. Humans become infected/infectious with tae-
niasis (i.e. the pre-patent period of 5–10 weeks before
shedding eggs is very short in comparison with the
55 years assumed human lifespan and can, therefore, be
mathematically omitted). There is no excess mortality in
humans with cysticercosis. We also assume that pigs do
not naturally clear the infection (there is no natural recov-
ery of pigs or the recovery rate of pigs is very slow in com-
parison with their death rate and can be omitted). The
recovered/immune compartment is, therefore, included
for pigs assumed to become immune after treatment. We
also assume that the number of eggs consumed by pigs
and humans has a negligible effect on the total number of
eggs present in the environment. The distribution of cysti-
cerci in pigs is assumed to be aggregated or overdispersed
[31]. Although we do not model explicitly this distribu-
tion, the heterogeneity of cyst burden in the pig popula-
tion is implemented by including two infected
compartments for pigs harbouring low and high cyst bur-
dens (IPL and IPH respectively).
Model equations
The rates of change with respect to time in the number
of susceptible humans (S); humans infected only with
taeniasis ITð Þ : harbouring the adult stage of T. solium
and therefore acting as definitive hosts; humans infected
only with cysticercosis Icð Þ : harbouring the larval stage
and therefore becoming dead-end ‘intermediate’ hosts;
and humans with both taeniasis and cysticercosis ITCð Þ
in the human population are given by the following or-
dinary differential equations (ODEs),
dS
dt
¼bH þ αIT þ ηIC þ ηITC−βLSIPL
NP
−
βHSIPH
NP
−θSE−dHS
ð1Þ
dIT
dt
¼βLSIPL
NP
þ βHSIPH
NP
− αþ 1þ rð ÞθEþ dHð ÞIT ð2Þ
dIC
dt
¼θSEþ αITC−
βLICIPL
NP
−
βHICIPH
NP
− ηþ dHð ÞIC ð3Þ
dITC
dt
¼ βLICIPL
NP
þ βHICIPH
NP
þ 1þ rð ÞθITE− αþ ηþ dHð ÞITC;
ð4Þ
where bH is the net number of humans births; and η are
the per capita human recovery rates from taeniasis and
cysticercosis, respectively; βL and βH are the pig to hu-
man transmission coefficients for pigs with low and high
cyst burdens, respectively; NP represents the pig popula-
tion size; θ is the egg to human cysticercosis transmission
coefficient (the transmission coefficients being the product
of the rate of contact and the transmission probability upon
contact); r (listed as rCysticercosis in Figure 1 and Table 1) is a
risk multiplier for cysticercosis in those with taeniasis
(to adjust for increased risk due to autoinfection), and
dH the per capita human mortality rate.
Human contact rate with pork is assumed to be fre-
quency dependent whilst human and pig contact rates
with eggs in the environment are assumed to be density
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dependent [32]. The rate of change in the number of in-
fectious eggs present in the environment (E) with re-
spect to time is
dE
dt
¼ δ IT þ ITCð Þ−dEE; ð5Þ
where δ is the egg production rate into the environ-
ment, and dE the egg loss rate from the environment
(capturing physical removal or loss of infectiousness/
viability).
The rates of change with respect to time in the num-
ber of susceptible pigs (SP), the number of infected pigs
harbouring a low cyst burden (IPL), the number of in-
fected pigs harbouring a high cyst burden (IPH) and the
number of immune (post-treatment (RP) or due to vac-
cination (VP)) pigs in the pig population (the intermedi-
ate hosts) are given in the following ODEs,
dSP
dt
¼ bP þ εRP−ϕτSPE− 1−ϕð ÞτSPE−dPSP ð6Þ
dIPL
dt
¼ ϕτSPE−dPIPL ð7Þ
dIPH
dt
¼ 1−ϕð ÞτSPE−dPIPH ð8Þ
dRP
dt
¼ − εþ dPð ÞRP ð9Þ
dVP
dt
¼ − εþ dPð ÞVP; ð10Þ
where bP is the net number of pig births; ε is the rate
of loss of immunity; ϕ is the proportion of infected
pigs that harbour low cyst burdens; τ is the egg to
pig transmission coefficient and dP the per capita pig
mortality rate.
The pig to human transmission coefficients can be
expressed as the product of the rate of contact and in-
fection probability,
βLϕ þ βH 1−ϕð Þ ¼ χπLð Þϕ þ χπL 1þ rcomsumption þ rinfection
 
1−ϕð Þ;
ð11Þ
where, χ represents the rate of obtaining a pork meal; πL
is the probability of becoming infected once infected
pork with low cyst burden is consumed; and rconsumption
and rinfection are the risk multipliers quantifying,
Fig. 1 Flow diagram of the transmission model. State variables are represented by compartments; flows or rates associated with model
parameters by arrows. The three model sections from top to bottom represent, respectively, human compartments, the environmental
compartment and pig compartments. (The silhouettes of the human, pig and tree are from https://commons.wikimedia.org/)
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respectively, the decreased chance of consumption
but increased chance of infection once pork is con-
sumed with a high cyst burden, relative to pork with
a low cyst burden (i.e., πH = πL + πL rconsumption + πL
rinfection). The model was coded and run in R [33]
using the Odin package [34].
A baseline scenario, with a human population of
10,000 and a pig population of 2000 was initiated to
run at stable equilibrium (endemic state) to represent
a sub-Saharan African setting (prevalence of taeniasis
in humans = 2%, prevalence of cysticercosis in
humans = 7% and prevalence of cysticercosis in pigs =
20% [35]). The model was then run at baseline for
30 years, after which single interventions or pairwise
combinations of interventions were simulated for a
further 20 years. The primary outcome measure of
interest was the cumulative number of human cysti-
cercosis cases averted over the period of the
intervention.
Interventions
EPICYST was used to assess the impact on infection
prevalence in humans and pigs of various interventions
applied singularly or in combination. The six single
interventions include two pig-focussed interventions:
vaccination and mass drug administration (MDA);
three behavioural/infrastructural interventions: improved
animal husbandry, improved sanitation and improved
meat inspection, as well as testing and treatment of
humans (test & treat) with taeniasis and not cysticercosis.
Table 1 Definition of variables and parameters used in the
transmission model
State variables Description
S Susceptible humans
IT Humans with taeniasis only
IC Humans with cysticercosis
only
ITC Humans with taeniasis and
cysticercosis
SP Susceptible pigs
IPL Pigs with cysticercosis (low cyst
burden)
IPH Pigs with cysticercosis (high cyst burden)
Rp Recovered (immune) pigs
Vp Vaccinated pigs
E Taenia solium eggs (in the environment)
Demographic
rates
Description Units
bH Human births (net rate, set to maintain
stable population size)
Month-1
dH Human death rate (per capita) Month
-1
bP Pig births (net rate, set to maintain
stable population size)
Month-1
dP Pig death rate (per capita) Month
-1
dE Egg removal/death rate (per capita) Month
-1
Transmission
parameters
Description Units
α Human recovery rate from taeniasis
(reciprocal of the average lifespan of the
adult Taenia solium worm)
Month-1
τ Egg to pig transmission coefficient
(product of the contact rate and the
probability of infection upon consumption
of a Taenia solium egg)
Month-1
ϕ Proportion of pigs with low cyst burden;
(1-ϕ) is the proportion of pigs with high
cyst burden
–
δ Egg production rate Month-1
ε Rate of loss of immunity in pigs Month-1
χ Rate of human pork meal procurement Month-1
πL Probability of human becoming infected
having consumed infected pork with a
low cyst burden
–
rconsumption Risk multiplier of discarding high
cyst-burden pork (relative to discarding
low cyst-burden pork)
–
rinfection Risk multiplier of infection on consuming
high cyst-burden pork (relative to
consuming low cyst-burden pork)
–
πH Probability of human becoming
infected having consumed infected
pork with a high cyst burden, πH = πL
(1 + rconsumption + rinfection)
–
βL Pig (low cyst burden) to human
transmission coefficient (a product
Month-1
Table 1 Definition of variables and parameters used in the
transmission model (Continued)
of the contact rate and the probability
of infection upon consumption of
infected pork, βL = χπL
βH Pig (high cyst burden) to human
transmission coefficient (a product
of the contact rate and probability
of infection upon consumption of
infected pork, βH = χπH
Month-1
θ Egg to human cysticercosis
transmission coefficient (a product
of the contact rate and probability
of infection upon consumption of
Taenia solium eggs)
Month-1
rCysticercosis Risk multiplier for cysticercosis
(applied to theta if the individual
has taeniasis)
–
η Human recovery rate from
cysticercosis (reciprocal of the
average duration of cysticercosis
infection in humans)
Month-1
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The implementation of each intervention is further
detailed below.
Pig MDA
Annual treatment of a proportion of all infected pigs
with a drug of given efficacy. Although MDA should en-
compass the whole pig population irrespective of infec-
tion status, we are not, at this stage, modelling the
possible impact of the suggested ‘prophylactic’ effect of
treatment, described in [34], on susceptible (uninfected)
pigs. Therefore, MDA is simulated in the model by treat-
ing already infected pigs. Every 12 months a proportion
of infected pigs are instantaneously transferred from the
IPL and IPH compartments to the SP or to the RP com-
partment. The proportion transferred to the latter (0.9)
is the product of multiplying the proportion treated (the
assumed therapeutic coverage = 90%) × the anthelmintic
efficacy (the cure rate = 99% [12]), motivated by a study
which found that oxfendazole-treated pigs did not be-
come re-infected for at least three months after treat-
ment and suggested that this protection may extend
for longer periods and cover the remaining lifetime of
the pigs [36].
Pig vaccination
Annual vaccination of a proportion of all susceptible pigs
with a vaccine of given efficacy. Every 12 months a pro-
portion of susceptible pigs are instantaneously transferred
from the SP compartment to the VP compartment. The
proportion would be the product of multiplying the
proportion vaccinated (the assumed vaccination cover-
age = 90%) × the vaccine efficacy (99%) [11]. However,
this proportion was adjusted downwards to account for
the fact that piglets may become infected/infectious before
a full vaccination course (this would include any necessary
boosters required) can be completed (at the age of
3 months). The proportion transferred to the RP compart-
ment was modified according to the following expression,
Adjusted proportion ¼ 0:9 0:99‐ 0:99 τE  3ð Þ½  ¼ 0:84
ð12Þ
with τ and E as described earlier and values given in
Table 2. (For the nominal value of τ = 2.36 × 10-10 the
number of eggs in the environment, E is 96 × 106.) The
efficacy of the vaccine in partially vaccinated pigs was
assumed to be zero.
Table 2 Parameter values for cysticercosis model (values are expressed per month). Minimum and maximum values were used for
the sensitivity analysis
Parameter Value Minimum Maximum Derivation (min, max) Reference
Human population size 10,000 – – – –
Pig population size 2000 – – – –
dH 0.0015 0.0013 0.0018 Average human life expectancy of 54 years (46, 64) [56]
dP 0.083 0.042 0.17 Average age at slaughter: 1 year (0.5, 2) [14, 28, 57]
dE
a 2 0.083 4 Average period of persistence of eggs in environment: 2 weeks
(1 week, 3 months)
[50–53, 58]
α 0.042 0.017 0.17 Average lifespan of T. solium: 2 years (0.5, 5) [59, 60]
τa 2.36 × 10-10 0.25τ 4τ – b
ϕ 0.8 0.1 0.9 – [61]
δ 960,000 640,000 1,800,000 – [60, 62]
ε 0.01 0.0075 0.0125 – [63]
χ 0.5 0.083 0.68 Assumes 1 pork meal = 200 g; 1.2 kg per capita per annum
(0.2 kg, 3.4 kg) = an average 6 pork meals per year
[64]
πLa 0.0084 0.25πL 4πL – b
rconsumption -0.25 -0.66 0 –
c
rinfection 1 0 2 –
c
θa 2.45 × 10-11 0.25θ 4θ – b
rCysticercosis 1 0 4 – [65]
η 0.0277 0.00167 0.083 Average duration of cysticercosis infection in humans:
3 years (1, 50)
[66]
aIndicates that a uniform distribution was specified for the LHS-PRCC, a triangle distribution was used for all other parameters
bParameter values were derived by equilibrium analysis
cWhere evidence in the literature was scarce to motivate parameter values, the values chosen were based upon expert opinion of plausible and conservatively
wide ranges and their influence was further explored in the sensitivity analysis
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Improved animal husbandry
Improved management of pig movement to decrease
probability of contact with Taenia solium eggs in the en-
vironment. An example of this intervention would be the
corralling of pigs in areas not likely to be contaminated
with human faecal material. Post implementation τ is de-
creased by 20% as a nominal value; this was varied in the
sensitivity analysis (see below).
Improved sanitation
Improved sanitation infrastructure to lead to a decrease
in the number of Taenia solium eggs entering the envi-
ronment. An example of this intervention would be the
installation and use of pit latrines. Post-implementation
δ is decreased by 20% as a nominal value; this was varied
in the sensitivity analysis (see below).
Improved meat inspection
Improvements to meat inspection practice to reduce the
rate of consumption of infected pork. We assume that
meat with a high cyst burden is more detectable than
meat with a low cyst burden. Post implementation βL
is decreased by 20% and βH is decreased by 40% as
nominal values; these were varied in the sensitivity
analysis (see below).
Test & treat
Testing for cysticercosis and/or taeniasis and treating
cases with taeniasis only. This is a hypothetical human-
targeted intervention, implemented under the assump-
tion that accurate, economically-viable, point-of-care,
discriminative diagnostics tests are widely available in fu-
ture. A proportion of humans with taeniasis (and not
with cysticercosis) are treated annually. Every 12 months
a proportion of humans with taeniasis (and not with cys-
ticercosis) are transferred from the IT compartment to
the S compartment. The proportion is the product of
multiplying the following factors: assumed therapeutic
coverage (90%) × sensitivity of test to T. solium (0.97) ×
specificity of the test to cysticercosis infection (0.98) ×
assumed drug efficacy (99%) [20, 21]. These values were
varied in the sensitivity analysis (see below).
Sensitivity analysis
To assess the sensitivity of the model output to the suite
of parameters and the uncertainty surrounding their
nominal values, a sensitivity analysis based on Latin-
hypercube sampling partial rank correlation coefficient
index (LHS-PRCC) was performed. The LHS was used
to produce samples of plausible parameter values. Fol-
lowing methodology set out in [37] and covered by [38],
the range of values for each parameter (from minimum
to maximum plausible values) was divided into N equal
intervals based upon a given distribution (e.g. uniform,
triangle, normal). Each parameter had one value drawn
from each interval, resulting in N sets of parameter values
and permitting an efficient exploration of parameter
space. The partial rank correlation coefficient (PRCC) is a
measure of the non-linear but monotonic relationship be-
tween a given parameter and model output, adjusted for
the effects of all other parameters in the model. Given two
paired variables, x and y; and their respective sample
means, x and y , a standard correlation coefficient, ρ, may
be calculated as,
ρ ¼
X
i
xi−xð Þ yi−yð ÞﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃX
i
xi−xð Þ2
X
i
yi−yð Þ
2
q : ð13Þ
We calculated the correlation between our output vari-
able, the cumulative number of human cysticercosis cases,
and a given model parameter as linear combination
between xj−x^j
 
and Y‐Y^
 
, where Xj is the rank-
transformed, sampled jth input parameter and Y our rank-
transformed state variable. For k samples we calculate X^ j
and Y^ with the following linear regression models,
X^j¼c0 þ
X
p ¼ 1
p ≠ j
k
cpXp ð14Þ
Y^¼b0 þ
X
p ¼ 1
p ≠ j
k
bpXp; ð15Þ
with b0 and c0 the model intercepts and bp and cp the re-
gression coefficients.
Together, the LHS and PRCC allow a computationally
efficient sensitivity analysis to be performed for a large
number of parameters [37, 38]. The significance of the
influence on model output of uncertainty surrounding a
parameter may be quantified by calculating the following
T value,
T ¼ ρ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðN−2−qÞ
1−ρ2
s
; ð16Þ
where N is the sample size (the number of intervals
per parameter) and q is the number of parameters for
which we adjust (the extra, influential model parameters
whose effect we wish to control for). The T statistic fol-
lows a Student’s t distribution with (N-2-q) degrees of
freedom [39].
The sensitivity of the output variable of interest in re-
lation to the intervention effectiveness (efficacy × cover-
age) was assessed univariately. All model parameters
were held at the standard, nominal value; the interven-
tion effectiveness/influence was sampled 1000 times
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from a distribution of plausible values. For pig MDA the
proportion transferred form the infected pig compart-
ments to the susceptible/immune compartments was
varied from 1 (best: 100% coverage × 100 efficacy) to
0.375 (worst: 50% coverage × 75% efficacy) and the pro-
portion of pigs treated that was assumed to have ac-
quired natural immunity varied from 1 (best) to 0
(worst). For the pig vaccination the proportion trans-
ferred from the susceptible to recovered/immune com-
partments was varied from to 1 (best: 100% coverage ×
100 efficacy) to 0.375 (worst: 50% coverage × 75% effi-
cacy). For the improved animal husbandry the egg-pig
transmission coefficient (τ) was reduced by 50% (best) or
10% (worst). For improved sanitation the egg production
rate (δ) was reduced by 50% (best) or 10% (worst). For
improved meat inspection the rate of humans contacting
infected pork with a low cyst burden (βL) was reduced
by 50% (best) or 10% (worst) and the rate of humans
contacting infected pork with a high cyst burden (βH)
was reduced by 80% (best) or 20% (worst). For the test
& treat scenario the proportion of humans with taeniasis
(and not with cysticercosis) transferred from the IT com-
partment to the S compartment was varied from 1 (best:
100% coverage, 100% efficacy and 100% sensitivity of diag-
nostic test to T. solium and 100% specificity of the test to
cysticercosis infection) to 0.3375 (worst: 50% coverage,
75% drug efficacy, 90% sensitivity of test to T. solium and
95% specificity of the test to cysticercosis infection).
The basic reproduction number, R0, of taeniasis
An expression for R0 (the number of new taeniasis cases
generated by a single human with taeniasis in an other-
wise susceptible population) was derived using the next
generation matrix approach detailed in [40–42],
R0 ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
τδ βH−βHθ þ βLθð Þ
dEdP 1þ rð Þθ þ dH þ αð Þ 1þ
1þ rð Þθ
ηþ dH þ α
 
H
3
s
;
ð17Þ
where H is the human population size, r is rCysticercosis as
listed in Table 1 and all remaining parameters have been
described above. The next generation matrix approach
assesses R0 as a demographic process (the cubic root in-
dicating that the life-cycle of the infection encompasses
three components: the human host, the pig host, and
the environment), analysing the acquisition of new infec-
tions over successive generations [42]. Further details of
the calculation of R0 using this approach are given in
Additional file 1.
Estimates of R0 were made by assessing 10,000 LHS
samples from the plausible range of parameter estimates.
We present the median and 2.5% and 97.5% quantiles as
our best estimate and 95% credible interval (95% CrI)
respectively.
Results
Model
EPICYST model outputs for the baseline (no intervention)
and six implemented single intervention scenarios are
shown in Fig. 2. All interventions, when applied singly,
demonstrated an ability to reduce the prevalence of taeni-
asis and cysticercosis in humans (Fig. 2a and b, respec-
tively), the number of eggs in the environment (Fig. 2c)
and the prevalence of cysticercosis in pigs (Fig. 2d).
A summary of the effect of single and pair-wise com-
binations of interventions on the primary outcome
measure of interest, the cumulative number of cysticerco-
sis cases averted, is shown in Fig. 3. For single interven-
tions, the human (test & treat) treatment scenario was
highly effective. We estimate that annual implementation
of the test & treat approach, targeting all people with
taeniasis but not cysticercosis, would avert a median
equal to 94% (95% credible interval, 95% CrI: 83–97%) of
human cysticercosis cases.
The pig-targeted interventions had a greater impact
[median % of human cysticercosis cases averted: pig
MDA 74% (95% CrI: 59–80%) and pig vaccination: 68%
(95% CrI: 52–73%)] than the improved husbandry, sani-
tation or meat-inspection interventions [median % of
human cysticercosis cases averted: husbandry 41% (95%
CrI: 22–62%), sanitation 54% (95% CrI: 32–77%) and
meat-inspection 56% (95% CrI: 40–71%)]. Deploying the
human test & treat intervention in combination with any
other intervention resulted in relatively small marginal
gains in the number of human cysticercosis cases averted.
Combinations of behavioural and/or pig-targeted inter-
ventions were considerably more effective when paired
than when applied singly. The combination of improved
sanitation and meat-inspection measures had the greatest
suppressive effect on infection prevalence of the strategies
that were not drug- or vaccine-based [median % of human
cysticercosis cases averted: sanitation + inspection 78%
(95% CrI: 65–87%)]. The impact of all pairwise combin-
ation is further detailed in Additional file 1 (Fig. S1).
Pig MDA and pig vaccination produced contrasting dy-
namics in the infected pig compartments (Fig. 2d). Vacci-
nation effected a much more smooth decline in the numbers
of infected pigs with respect to time than MDA (Fig. 2d).
Improved sanitation and improved animal husbandry
produced equivalent effects on the prevalence of taenia-
sis in humans and of cysticercosis in pigs (Fig. 2a, d),
but contrasting effects in the prevalence of humans
cysticercosis cases and the number of T. solium eggs in
the environment (Fig. 2b, c).
The basic reproduction number of taeniasis
For the wide range of plausible parameter values shown
in Table 2, the (median) estimate for R0 was 1.4 (95%
CrI: 0.5–3.6).
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Sensitivity analysis
The sensitivity analysis indicated that of the 16 model
parameters, 8 of them, and their associated uncertainty,
were particularly influential on model output. A summary
of the calculated PRCC values for all parameters in the base-
line model is presented in Fig. 4. Parameters α;dE; δ; χ; θ; τ;
ϕ and πL had highly statistically significant relationships
with the outcome of interest, in part reflecting the high de-
gree of uncertainty surrounding some parameter estimates.
The parameters rconsumption and rinfection, for which very little
is known, had little relative influence on the outcome.
The test & treat of humans with taeniasis and the pig-
focussed interventions (MDA and vaccination) proved
much more robust in respect to changes in the potential
coverage or efficacy of the intervention in comparison to
improved husbandry, sanitation and meat-inspection in-
terventions (Fig. 3).
Discussion
In response to the call by the WHO for developing a val-
idated strategy for the control and elimination of T.
solium taeniasis/cysticercosis [1], and to the research
priorities highlighted by the WHO for zoonoses and
marginalized infections [6], we have developed EPICYST,
a transmission model to explore in-depth the transmis-
sion dynamics of the taeniasis/cysticercosis disease
system and assess a range of interventions applied singly
or in combination.
Cysticercosis infections in humans are specifically
modelled, capturing this clinically-relevant aspect of the
parasite’s life history. The extra complexity associated
with incorporating human cysticercosis into the model,
as illustrated by the model diagram (Fig. 1) and example
output (Fig. 2), is an important inclusion. Output from
the model indicates that the prevalence of human cysti-
cercosis is non-linearly associated with the presence of
taeniasis in humans, highlighting the importance of spe-
cifically modelling the human cysticercosis dynamics.
Model outputs also highlight complex interactions be-
tween specific interventions, the prevalence of taeniasis
and the prevalence of cysticercosis. For example, im-
proved sanitation and animal husbandry are projected to
Fig. 2 Impact of single interventions on: a the prevalence of taeniasis in humans, b the prevalence of cysticercosis in humans, c the number of
eggs in the environment, and d the prevalence of cysticercosis in pigs. The black horizontal line represents the infection levels according to the
baseline model, run at stable equilibrium in the absence of any intervention; the orange line represents enhanced husbandry; the green dashed
line improved sanitation, the purple line improved meat inspection; the mauve line vaccination of the pig population, the blue line pig mass drug
administration (MDA) and the dark red line human test & treat
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have very similar effects on porcine cysticercosis and hu-
man taeniasis but different dynamics with regard to hu-
man cysticercosis; sanitation impacts prevalence of
human cysticercosis as it decreases the probability of
human-egg contact, animal husbandry does not (Fig. 2b).
This example also highlights the benefits of including
an environmental compartment for eggs in the model
as it facilitates the implementation of targeted inter-
ventions that impact the parasite’s life-cycle at very
specific points. We have hoped to make this model
flexible in other ways to a wide range of potential
baseline and intervention scenarios. Inclusion of a
mixture of density- and frequency-dependent rates
gives the model a degree of flexibility to cope
Fig. 4 Sensitivity of model output to parameter values and their uncertainty. The metrics used is the partial rank correlation coefficient (PRCC) as
described in the Main Text. ***P≤ 0.001; ****P ≤ 0.0001
Fig. 3 Impact of interventions on the number of human cysticercosis cases. Single a and the most effective b pairwise combinations of
interventions from the behavioural, pig-targeted and human categories (all pairwise combinations are included in the SI). Intervention colours as
in Fig. 2. Box and whiskers represent the range of impact estimates from 1000 sensitivity draws of intervention efficacy parameters, the midline
represents the median impact, the hinges the 25th and 75th percentiles and whiskers the range. Points show individual run output. Due to the
large amount of uncertainty in parameters estimates, the impact of parameter estimates was explored separately (see Fig. 4)
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appropriately with scenarios covering a range of hu-
man and pig population densities.
The hypothetical human test & treat approach was ex-
tremely effective. However it must be stressed that this
is currently still a speculative (and optimistic) assess-
ment of a potential intervention. Although there cur-
rently are tests for detection of stage-specific human T.
solium taeniasis antibodies and neurocysticercosis anti-
bodies [43] that have been used in a number of field
studies [44, 45], barriers exist to the introduction and
financing of such an intervention on a large scale. The
efficacy of a human test & treat strategy would also be
influenced by the level of (taeniasis-cysticercosis) co-
infection in the community, with high levels of co-
infection hampering success.
The assessment of alternative approaches to human
chemotherapy shows that the pig-targeted interventions,
MDA and vaccination of pigs, are the most effective to
reduce the prevalence of human cysticercosis in a short
period. Both of these interventions, when applied annu-
ally at high coverage and assuming high efficacy reduced
the median number of potential new cysticercosis cases
by > 65% (Fig. 3). Pig MDA performed marginally better
than pig vaccination averting additional cases over pig
vaccination. The effect of the vaccine is less for two rea-
sons: (i) there is a period prior to full vaccination of
around 3 months in which pigs may become infected;
and (ii) there is a small difference between the two inter-
ventions in lag times between intervention implementa-
tion and intervention effect. Pig MDA is assumed to
clear immediately most of the infectious reservoir in
pigs, whilst the pig infectious reservoir clears as pigs die
or are slaughtered and is not replenished with the vac-
cination intervention. In settings where it may be diffi-
cult to achieve high coverage in a cost-effective manner,
either of these interventions would be capable of having
extremely positive public health effects through annual
implementation. Applying pig MDA or pig vaccination in
conjunction with each other or with any of the other in-
terventions considered resulted in small marginal gains as
the performance of the pig-focussed interventions when
applied on their own was already very good. Any pro-
grammatic decisions to implement either human test &
treat, vaccination or MDA campaigns would need to con-
sider the long-term sustainability of such an effort, as ces-
sation without achieving elimination would likely lead to
return to pre-intervention equilibrium prevalence levels.
The potential ability of improved animal husbandry,
sanitation and meat inspection to reduce the prevalence
of taeniasis and cysticercosis was also demonstrated. The
suppressive effect on disease prevalence was less pro-
nounced than that of the human- and pig-targeted inter-
ventions but would still be of considerable public-health
benefit. Application of these interventions in combination
resulted in increased effectiveness over their use singly; the
combination of improved meat inspection and sanitation
was of similar effectiveness to a pig vaccination campaign
but less effective than human test & treat in the scenarios
modelled (Fig. 3b). The wide-ranging public health benefits
associated with infrastructure-based interventions espe-
cially must not be considered in isolation. Improved sanita-
tion infrastructure would also greatly benefit efforts to
combat other severe conditions including diarrhoeal
disease [46] and other helminth infections [47]. Com-
binations of MDA of pigs or their vaccination and
improved sanitation resulted in high levels of impact
against taeniasis and cysticercosis and would comple-
ment a “One Health” approach [48].
We have analysed the model to derive an equation for
the basic reproduction number of taeniasis. The calcula-
tion summarises the relevant rates and processes that
are responsible for the dynamics of the parasite through-
out its life-cycle. The median estimate was a value of 1.4
(95% CrI: 0.5–3.6), slightly lower than the estimate de-
rived from the previous model (1.75 [28]). The wide con-
fidence (credible) interval around the value estimated in
this paper is another reflection of the high level of uncer-
tainty surrounding a number of parameters in the model.
This expression provides us with a guide from which we
can determine the threshold of extinction/persistence in
the theoretical (deterministic) system. Furthermore, we
can explore the relationship between individual parame-
ters and this threshold. For instance, based on our model
output and assumptions, we observe that a number of pa-
rameters (e.g. α, the human recovery rate from taeniasis
and, dE, the egg removal/death rate) are non-linearly asso-
ciated with R0, and may warrant further attention.
The sensitivity analysis is an extremely important com-
ponent of this analysis and, it must be stressed that all
conclusions drawn from model outputs are made in the
presence of considerable uncertainty surrounding a num-
ber of important model parameters. This lack of data is,
unfortunately, a common problem and one highlighted by
the Disease Reference Group on Zoonoses and Margina-
lised Infectious Diseases [49]. Although a number of stud-
ies have approached the problem of estimating the
persistence of eggs in the environment [50–54], the re-
moval rate of eggs, dE, remains a highly uncertain and in-
fluential parameter. Furthermore, this parameter is likely
to be most strongly influenced by external meteorological,
ecological and seasonal factors not included in this model.
As expected, the transmission parameters, θ and τ, and ϕ,
are all influential on model output and also likely to be
heterogeneous across a wide range of epidemiological sce-
narios. The influence of the human recovery rate from
taeniasis, α, is also statistically significant. Pig-focussed in-
terventions are also sensitive to model assumptions re-
garding the acquisition of immunity.
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From the above, we identify key gaps in the fundamen-
tal scientific knowledge that need to be addressed for
more accurate parameterisation of transmission models
of taeniasis/ cysticercosis, namely: (i) the persistence
of T. solium eggs in the environment with respect to
climate and seasonality; (ii) the average lifespan of the
adult worm in the human host (the reciprocal of α);
and (iii) the acquisition of immunity to infection in
the pig population.
The sensitivity of projected intervention impact has
also been assessed. Pig MDA, pig vaccination and
human test & treat appear to be robust to variability in
assumed intervention coverage and efficacy relative to
the other singly implemented interventions. There are
larger uncertainties surrounding the efficacy and effect
size of the non-chemotherapeutic interventions than for
anthelmintic treatment or vaccination, and this is highlighted
in this analysis.
Limitations
In addition to uncertainty surrounding parameter esti-
mates, we have identified a number of other limitations.
The model does not specifically include the development of
neurocysticercosis in human patients with cysticercosis.
This stage was not included due to a lack of data but is of
critical importance due to the clinical implications of neu-
rocysticercosis. Behavioural change is particularly hard to
parameterise; this is reflected in the wide range of parame-
ters that are associated with human behaviours in the sensi-
tivity analysis. For the same reason, we did not model an
educational intervention. Conducting studies that quantify
the impact of such interventions on transmission remains
an important research gap. We have made simplifying as-
sumptions regarding a number of potential heterogeneities
in the system; there is no age structure or heterogeneity of
risk in humans and any spatial or seasonal elements have
been omitted. We assessed interventions under conditions
pertaining to a specific endemic state and generalisations of
results are presented with this in mind. We have developed
a deterministic model which may not be suitable for
assessing targets of disease elimination, when stochastic
elements become increasingly important. In future work,
stochastic approaches such as those demonstrated in
previous models [28], will be explored, as we are planning
to develop an individual-based analogue of EPICYST. How-
ever, the validity of models with increased complexity will
depend critically on an increase in available data for param-
eterisation. It will be important to fit and validate the model
with field data and longitudinal intervention studies,
preferably from a wide range of epidemiological scenarios.
Conclusions
We are able to make a number of recommendations to
facilitate progress towards the 2015 and the 2020 goals
laid out in the WHO NTD roadmap [2] and that
support those made by an expert panel to the WHO in
2011 [55]. Firstly, the potential for a human test & treat
strategy to be highly effective supports calls for the
prioritisation of further research into the development of
affordable, fast and accurate point-of-care diagnostics to
distinguish between taeniasis and cysticercosis [43–45].
Secondly, pig MDA or pig vaccination is capable of
effecting a significant impact on averting human cysti-
cercosis at present, warranting their further evaluation
in large-scale field trials. Thirdly, where a more inte-
grated approach to public and veterinary health is called
for, combinations of improved animal husbandry, sanita-
tion and meat inspection may be preferable.
In addition, we have identified priority areas for further
research for the improvement of taeniasis/cysticercosis
transmission models, including the persistence of T. solium
eggs in the environment, the duration of adult worm
lifespan, and the acquisition of pig immunity to infection.
The model allows scenario-specific implementation of
a range of interventions or combinations of interven-
tions, of which a non-exhaustive list have been explored.
We hope that the model presented will be a valuable
tool for scientists and policy makers to guide future
research efforts and inform policy, in addition to acting
as a foundation for future modelling developments and
providing a framework for the assessment of the cost-
effectiveness of interventions [23].
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Additional file 1: Derivation of an expression for the basic reproduction
number, R0, for taeniasis in humans. Figure S1: Impact of pairwise
combinations of interventions on the number of human cysticercosis
cases. Box and whiskers represent the range of impact estimates from
1000 sensitivity draws of efficacy parameters, the midline represents the
median impact, the hinges the 25th and 75th percentiles and whiskers the
range. Points show individual run output. Due to the large amount of
uncertainty in parameters estimates, the impact of parameter estimates
was explored separately. (DOCX 2105 kb)
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